How patients decide on thyroid cancer care
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how people make decisions about early-stage thyroid cancer care. If your tumor is small and hasn't spread, researchers want to learn from your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed or doctors suspect you have thyroid cancer.
- Your doctor has not said you need to have your whole thyroid removed.
- Your tumor is smaller than about 4 centimeters (1.6 inches).
- Your cancer has not spread to lymph nodes, other body parts, or outside the thyroid.
- You can have conversations in English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps patients with small, low-risk thyroid cancer choose between active surveillance and immediate surgery. It focuses on shared decision-making to match the treatment to your values and preferences.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
This trial tests whether an online educational program, completed before your first clinic visit, helps you better understand your thyroid cancer diagnosis and treatment options. It is designed for people with small thyroid nodules that are likely or confirmed to be a common type of thyroid cancer.
This trial tests whether an educational video helps people feel more confident and satisfied when giving consent for thyroid surgery. It is for adults having their first thyroid surgery, such as a partial or full removal of the thyroid gland.
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
This study compares two approaches after thyroid surgery: giving radioactive iodine right away versus deciding based on follow-up test results. It aims to see which approach better helps people with intermediate-risk differentiated thyroid cancer.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.